![]() SB-284851-BT structure
|
Common Name | SB-284851-BT | ||
---|---|---|---|---|
CAS Number | 219769-23-0 | Molecular Weight | 443.52 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C26H26FN5O | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of SB-284851-BTSB-284851-BT is an inhibitor of BRD4/p38α/BRDT. SB-284851-BT inhibits BRD4-BD1 (IC50=1.7 µM), p38α (Kd=0.47 nM), BRDT (1) (IC50=18 µM) and BRD4 (1)(IC50=3.7 µM). SB-284851-BT reduces IL-8 production by inhibiting p38α, as well as inhibiting BRD4 to down-regulates c-Myc and NF-κB gene pathways in cancer. SB-284851-BT can combined with the bromine domain and extra terminal (BET)[1][2]. |
Name | SB-284851-BT |
---|
Description | SB-284851-BT is an inhibitor of BRD4/p38α/BRDT. SB-284851-BT inhibits BRD4-BD1 (IC50=1.7 µM), p38α (Kd=0.47 nM), BRDT (1) (IC50=18 µM) and BRD4 (1)(IC50=3.7 µM). SB-284851-BT reduces IL-8 production by inhibiting p38α, as well as inhibiting BRD4 to down-regulates c-Myc and NF-κB gene pathways in cancer. SB-284851-BT can combined with the bromine domain and extra terminal (BET)[1][2]. |
---|---|
Related Catalog | |
Target |
p38α:0.47 nM (Kd) BRD4-BD1:1.7 μM (IC50) BRDT (1):18 μM (IC50) BRD4(1):3.7 μM (IC50) |
References |
Molecular Formula | C26H26FN5O |
---|---|
Molecular Weight | 443.52 |